Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 8 Uterine Cervical Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Recurrence 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Cisplatin 208 Radiotherapy 152 Cetuximab 118 pembrolizumab 98 Fluorouracil 80 Docetaxel 78 Paclitaxel 67 Carboplatin 66 Radiotherapy, Intensity-Modulated 60 Nivolumab 34 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 durvalumab 17 Surveys and Questionnaires 17 Surgical Procedures, Operative 17 Standard of Care 17 Cyclophosphamide 17 Pemetrexed 16 Magnetic Resonance Spectroscopy 16 atezolizumab 15 Capecitabine 15 Bevacizumab 14 Radiosurgery 13 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Amifostine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡